From October 4 to 8, 2025, Central European Summer Time, the 38th Annual Congress of the European Association of Nuclear Medicine (EANM) was successfully held in Barcelona. Coinciding with the 40th anniversary of the European Association of Nuclear Medicine, this year's conference reached an unprecedented scale, attracting over 8,600 nuclear medicine professionals. Ma Ruili, General Manager of Sichuan Longevous Beamtech Co.,Ltd, and Chen Mo, Deputy General Manager, led the delegation to participate.

The European Association of Nuclear Medicine (EANM), founded in 1985, is one of the top conferences in the global nuclear medicine field. Alongside the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting in the United States and the Asia Oceania Congress of Nuclear Medicine and Biology (AOCNMB), it is recognized as one of the three major events in the world of nuclear medicine. Its aim is to advance scientific education in nuclear medicine and promote and coordinate communication regarding diagnostic and therapeutic methods across Europe and beyond.

During the opening ceremony of this year's conference, data released by the organizing committee showed that the number of abstract submissions from Chinese academic journals ranked first globally. This touch of "Chinese red" fully reflects the contributions of Chinese scholars on the global nuclear medicine stage. As a pioneer in domestic medical cyclotrons, LBT showcased its latest technologies and products to the world at the conference and officially announced that it has obtained CE certification. This signifies that LBT has acquired the key to entering the European market. This certification, along with ISO 13485, marks the company's products as approved for entry into the European Union and the European Economic Area, with its quality management system meeting international standards. Building on this foundation, LBT is committed to providing customers with higher-quality products and services.

(Photo: LBT General Manager Ma Ruili and Deputy General Manager Chen Mo with Huang Gang, President of the Nuclear Medicine Physicians Branch of the Chinese Medical Doctor Association)

During the conference, LBT presented its self-developed comprehensive solution for radiopharmaceuticals, attracting numerous international professionals for exchanges. This solution integrates advanced medical cyclotron equipment, radiopharmaceutical preparation technology, and a full-process quality control system. It not only demonstrates China's technical strength in the field of nuclear medical equipment but also offers a new, efficient, and safe option for isotope production to global medical institutions, research institutes, and related enterprises.

LBT's booth garnered significant attention during the conference. Clients from Italy and Belgium engaged in in-depth discussions with LBT's technical team on isotope production processes and equipment parameter optimization. Partners from India and Kazakhstan focused on business collaborations such as project planning, system support, and return on investment. Clients from the Czech Republic and Hungary showed strong interest in LBT's cyclotron system after learning about its efficient isotope production capacity, intelligent operation interface, and comprehensive safety protection design.

This participation in the EANM Congress marks another milestone in LBT's globalization journey. LBT will take this appearance as a new starting point, continuously deepening technological innovation and service optimization, and steadily advancing toward the grand goal of becoming a "world-leading nuclear medicine enterprise."